Factors for recurrent stroke among Asian patients with non-valvular atrial fibrillation under non-vitamin K antagonist oral anticoagulant therapy.

CONCLUSION: Atrial fibrillation patients with underlying malignancy or concurrently use of EIAED may have increased risk of treatment failure in secondary stroke prevention.
PMID: 32107099 [PubMed - as supplied by publisher]

Source: J Formos Med Assoc - February 23, 2020 Category: General Medicine Authors: Lin SY, Tang SC, Tsai LK, Yeh SJ, Huang CF, Jeng JS Tags: J Formos Med Assoc Source Type: research